Abstract
Hydatid disease caused by Echinococcus granulosus presents medical, veterinary and economic problems worldwide. Hydatidosis can be treated by medical, surgical and percutaneous modalities. Benzoimidazole carbamates are effective against E. granulosus. Although mebendazole, the first benzoimidazole used, has some beneficial effects on the disease in selected patients, it has also been associated with treatment failure in some cases, perhaps because of its poor absorption. Albendazole, a more recently developed benzoimidazole, is more effective than mebendazole. Praziquantel, an isoquinoline derivative, has recently shown value in the treatment of human echinococcal disease and its use in combination with albendazole is recommended in some patients. Ultrasound guided cyst puncture is another choice of treatment which has been used successfully in selected patients, although anaphylactic and allergic reactions due to spillage of the cyst contents have occurred. Surgical therapy in echinococcal hydatid disease is indicated for large cysts with multiple daughter cysts, superficially located single liver cysts which have a risk of rupture, complicated cysts such as those accompanied by infection, compression or obstruction, and cysts located in vital organs or which are exerting pressure on adjacent vital organs. However, surgical therapy carries high risk of mortality, morbidity or recurrence. Therefore, medical therapy may be an alternative option in uncomplicated cysts and in patients at high risk from surgery. The adjuvant use of drugs with surgery and percutaneous treatment can also be recommended for some patients.
Similar content being viewed by others
References
Tuazon AO, Pasterkamp H. Hydatid disease of the lung (pulmonary hydatidosis). In: Chernick V, Boat TF, Kendig EL, editors. Kendig’s disorders of the respiratory tract in children. Philadelphia (PA): WB Saunders, 1998: 1050–7
WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Organ 1996; 74: 231–42
Mutaf O, Arikan A, Yazici M, et al. Pulmonary hydatidosis in children. Eur J Pediatr Surg 1994; 4: 70–3
Solak H, Yeniterzi M, Yüksek T, et al. The hydatid cysts of the lung in children and results of surgical treatment. Thorac Cardiovasc Surg 1990; 38: 45–7
Aytac A, Yurdakul Y, Ikizler C, et al. Pulmonary hydatid disease: report of 100 patients. Ann Thorac Surg 1977; 23: 145–51
Anadol D, Göçmen A, Kiper N, et al. Hydatid disease in childhood: a retrospective analysis of 376 cases. Pediatr Pulmonol 1998; 26: 190–6
Chaouachi B, Nouri A, Ben Salah S, et al. Hydatid cyst of the lung in children: diagnosis and therapeutic aspects based upon a series of 643 cases [in French]. Pediatrie 1988; 43: 769–73
McIntyre A. Hydatid disease in children in South Australia. Med J Aust 1971; 1: 1064–5
Blanton R. Echinococcosis (Echinococcus granulosus and E. multilocularis). In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. Philadelphia (PA): Saunders, 2000: 1079–81
Turner JA. Cestodes. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Philadelphia (PA): Saunders, 1998: 2513–29
Ammann RW, Eckert J. Cestodes: echinococcus [published erratum appears in Gastroenterol Clin North Am 1996; 25 (4): vii]. Gastroenterol Clin North Am 1996; 25: 655–89
Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 1992; 5: 248–61
Nutman TB, Weller PF. Cestodes. In: Faucu AS, Braunwald E, Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine. New York (NY): McGraw Hill, 1998: 1224–7
Teggi A, Lastilla MG, De Rosa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 1993; 37: 1679–84
Todorov T, Vutova K, Mechkov G, et al. Experience in the chemotherapy of severe, inoperable echinococcosis in man. Infection 1992; 20: 19–24
Keshmiri M, Baharvahdat H, Fattahi SH, et al. A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis. Eur Respir J 1999; 14: 503–7
Morris DL, Dykes PW, Marriner S, et al. Albendazole: objective evidence of response in human hydatid disease. JAMA 1985; 253(14): 2053–7
Singounas EG, Leventis AS, Sakas DE, et al. Successful treatment of intracerebral hydatid cysts with albendazole: case report and review of the literature. Neurosurgery 1992; 31: 571–4
Gil-Grande LA, Boixeda F, Garcia-Hoz F, et al. Treatment of liver hydatid disease with mebendazole: a prospective study of thirteen cases. Am J Gastroenterol 1983; 78: 584–7
Kammerer W, Schantz PM. Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. Am J Trop Med Hyg 1984; 33: 132–7
Luder PJ, Siffert P, Witassek F, et al. Treatment of hydatid disease with high oral doses of mebendazole. Eur J Clin Pharmacol 1986; 31: 443–8
Davis A, Dixon H, Pawlowski ZS. Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2). Bull World Health Organ 1989; 67: 503–8
Göçmen A, Toppare MF, Kiper N. Treatment of hydatid disease in childhood with mebendazole. Eur Respir J 1993; 6: 253–7
Messaritakis J, Psychou P, Nicolaidou P, et al. High mebendazole doses in pulmonary and hepatic hydatid disease. Arch Dis Child 1991; 66: 532–3
Rowley AH, Shulman ST, Donaldson JS, et al. Albendazole treatment of recurrent echinococcosis. Pediatr Infect Dis J 1988 Sep; 7(9): 666–7
Steiger U, Cotting J, Reichen J. Albendazole treatment of echinococcosis in humans: effects of microsomal metabolism and drug tolerance. Clin Pharmacol Ther 1990; 47: 347–53
Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomized controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993; 342: 1269–72
Taylor DH, Morris DL, Richards KS. Echinococcus granulosus: in vitro maintenance of whole cysts and the assessment of the effects of albendazole sulphoxide and praziquantel on the germinal layer. Trans R Soc Trop Med Hyg 1989; 83: 535–8
Aggarwal P, Wali JP. Albendazole in the treatment of pulmonary echinococcosis. Thorax 1991; 46: 599–600
Morris DL, Dykes PW, Dickson B, et al. Albendazole in hydatid disease. BMJ 1983; 286: 103–4
Mohamed AE, Yasawy MI, Al Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology 1998; 45: 1690–4
Pearson RD. Agents active against parasites and pneumocystis carinii. In: Mandell GL, Benett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia (PA): Churchill Livingstone, 2000: 2956–65
Taketomo CK, Hodding JH, Kraus DM. Pediatric dosage handbook. Hudson (OH): Lexi-Comp Inc, 1999; 745–6
Yasawy MI, Al Karawi MA, Mohamed ARE. Combination of praziquantel and albendazole in the treatment of hydatid disease. Trop Med Parasital 1993; 44: 192–4
Redzic B, Radulovic S, Stankovic N, et al. Praziquantel in the treatment of human echinococcosis [in Roman]. Vojnosanit Pregl 1995; 52: 155–9
Salto E, Juarez E, Roiz MP, et al. Combined chemotherapy (mebendazole plus praziquantel) in patients with hydatidosis [in Spanish]. Enferm Infec Microbiol Clin 1991; 9: 527–9
Cobo F, Yarnoz C, Sesma B, et al. Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatidosis caused by Echinococcus granulosus. Trop Med Int Health 1998; 3: 462–6
Akhan O, Özmen MN, Dinçer A, et al. Percutaneous treatment of pulmonary hydatid cysts. Cardiovasc Intervent Radiol 1994; 17: 271–5
Akhan O, Özmen MN. Percutaneous treatment of liver hydatid cysts. Eur J Radiol 1999; 32: 76–85
Akhan O, Özmen MN, Dinçer A, et al. Liver hydatid disease: Long-term results of percutaneous treatment. Radiology 1996; 198: 259–64
Üstünsöz B, Akhan O, Kamiloglu MA, et al. Percutaneous treatment of hydatid cysts of the liver: long-term results. AJR Am J Roentgenol 1999; 172: 91–6
Akhan O, Üstünsöz B, Somuncu I, et al. Percutaneous renal hydatid cyst treatment: long-term results. Abdom Imaging 1998; 23: 209–13
Akhan O, Bilgiç S, Akata D, et al. Percutaneous treatment of an orbital hydatid cyst: a new approach. J Ophthalmol 1998; 125: 877–9
Schantz PM, Bossche VH, Eckert J. Chemotherapy of larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd 1982; 67: 5–26
Sayek I, Yalin R, Sanac Y. Surgical treatment of hydatid disease of the liver. Arch Surg 1980; 115: 847–50
Al Karawi MA, el-Shiekh Mohamed AR, Yasawy MI. Advances in diagnosis and management of hydatid disease. Hepatogastroenterology 1990; 37: 327–31
Mottaghian H, Saidi F. Postoperative recurrence of hydatid disease. Br J Surg 1978; 65: 237–42
Morris DL. Pre-operative albendazole therapy for hydatid cyst. Br J Surg 1987; 74(9): 805–6
Amir-Jahed AK, Fardin R, Farzad A, et al. Clinical echinococcosis. Ann Surg 1975; 182: 541–6
Besim H, Karayalcin K, Hamamci O, et al. Scolicidal agents in hydatid cyst surgery. HPB Surg 1998; 10: 347–51
Garcia L, Alonso E, Gonzalez-Uriarte J, et al. Evaluation of scolicidal agents in an experimental hydatid disease model. Eur Surg Res 1997; 29: 202–8
Rebhandl W, Turnbull J, Felberbauer FX, et al. Pulmonary echinococcosis (hydatidosis) in children: results of surgical treatment. Pediatr Pulmonol 1999; 27: 336–40
Erzurumlu K, Hokelek M, Gonlusen L, et al. The effect of albendazole on the prevention of secondary hydatidosis. Hepatogastroenterology 2000; 47: 247–50
Turkcapa AG, Ersoz S, Gungor C, et al. Surgical treatment of hepatic hydatidosis combined with perioperative treatment with albendazole. Eur J Surg 1997; 163: 923–8
Gollackner B, Langle F, Auer H, et al. Radical surgical therapy of abdominal cystic hydatid disease: factors of recurrence. World J Surg 2000; 24: 717–21
Behrns KE, Van Heeden JA. Surgical management of hepatic hydatid disease. Mayo Clin Proc 1991; 66: 1193–5
Safioleas M. Surgical treatment for lung hydatid disease. World J Surg 1999; 23: 1181–5
Yalcinkaya I, Er M, Ozbay B, et al. Surgical treatment of hydatid cyst of the lung; review of 30 cases. Eur Respir J 1999; 13:441–4
Salih OK, Topcuoglu MS, Celik SK, et al. Surgical treatment of hydatid cysts of the lung: analysis of 405 patients. Can J Surg 1998; 41: 131–5
Ammann RW. Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar hydatid disease. Parasital Res 1991; 77: 290–3
Wilson JF, Rausch RL, Wilson FR. Alveolar hydatid disease: review of surgical experience in 42 cases of active disease among Alaskan Eskimos. Ann Surg 1995; 221: 316–23
Ammann RW. Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis. J Hepatol 1998; 29: 994–8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anadol, D., Özçelik, U., Kiper, N. et al. Treatment of Hydatid Disease. Paediatr Drugs 3, 123–135 (2001). https://doi.org/10.2165/00128072-200103020-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128072-200103020-00005